Review



igg1 human fc sequence  (Twist Bioscience)


Bioz Verified Symbol Twist Bioscience is a verified supplier
Bioz Manufacturer Symbol Twist Bioscience manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    Twist Bioscience igg1 human fc sequence
    Animal <t>IgG</t> and serological competition. (A) IgG and serological competition schematic. Anti-His pAb captures SARS-CoV-2 spike protein. Immunized sera or IgG from small animals are used as competitors to block ACE2-IgHu receptor binding when premixed. ACE2-IgHu remaining is determined from an anti-human-HRP colorimetric readout. (B) IgGs present in a vaccinated BALB/c mouse block ACE2-IgHu binding with greater effect when the full-length SARS-CoV-2 S1-S2 spike protein is immobilized versus the S1 subunit by itself. (C) Area under the concentration-time curve (AUC) schematic displaying the larger area for uninhibited ACE2 binding versus the area from curves showing competition with ACE2. (D) AUC of IgGs purified from immunized rabbit sera (IgGr low dose, blue; IgGr high dose, red) versus naive IgGr or day 0 IgGr. (E) AUC of sera from immunized rabbits (low dose rabbit sera, blue; high dose rabbit sera, red) versus naive rabbit sera or day 0 rabbit sera. (F) AUC of sera from immunized guinea pigs at week 2 (dark blue) and individual animals (blue), naive sera (gray), and pooled day 0 sera from all animals (black). The pooled immunized curve displayed a comparable AUC to the average AUC from all individual immunized animals.
    Igg1 Human Fc Sequence, supplied by Twist Bioscience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+fc+sequence/ptwist+amp+high+copy/pmc07587116-45-3-19
    Average 90 stars, based on 1 article reviews
    igg1 human fc sequence - by Bioz Stars, 2026-11
    90/100 stars

    Images

    1) Product Images from "SARS-CoV-2 Assays To Detect Functional Antibody Responses That Block ACE2 Recognition in Vaccinated Animals and Infected Patients"

    Article Title: SARS-CoV-2 Assays To Detect Functional Antibody Responses That Block ACE2 Recognition in Vaccinated Animals and Infected Patients

    Journal: Journal of Clinical Microbiology

    doi: 10.1128/JCM.01533-20

    Animal IgG and serological competition. (A) IgG and serological competition schematic. Anti-His pAb captures SARS-CoV-2 spike protein. Immunized sera or IgG from small animals are used as competitors to block ACE2-IgHu receptor binding when premixed. ACE2-IgHu remaining is determined from an anti-human-HRP colorimetric readout. (B) IgGs present in a vaccinated BALB/c mouse block ACE2-IgHu binding with greater effect when the full-length SARS-CoV-2 S1-S2 spike protein is immobilized versus the S1 subunit by itself. (C) Area under the concentration-time curve (AUC) schematic displaying the larger area for uninhibited ACE2 binding versus the area from curves showing competition with ACE2. (D) AUC of IgGs purified from immunized rabbit sera (IgGr low dose, blue; IgGr high dose, red) versus naive IgGr or day 0 IgGr. (E) AUC of sera from immunized rabbits (low dose rabbit sera, blue; high dose rabbit sera, red) versus naive rabbit sera or day 0 rabbit sera. (F) AUC of sera from immunized guinea pigs at week 2 (dark blue) and individual animals (blue), naive sera (gray), and pooled day 0 sera from all animals (black). The pooled immunized curve displayed a comparable AUC to the average AUC from all individual immunized animals.
    Figure Legend Snippet: Animal IgG and serological competition. (A) IgG and serological competition schematic. Anti-His pAb captures SARS-CoV-2 spike protein. Immunized sera or IgG from small animals are used as competitors to block ACE2-IgHu receptor binding when premixed. ACE2-IgHu remaining is determined from an anti-human-HRP colorimetric readout. (B) IgGs present in a vaccinated BALB/c mouse block ACE2-IgHu binding with greater effect when the full-length SARS-CoV-2 S1-S2 spike protein is immobilized versus the S1 subunit by itself. (C) Area under the concentration-time curve (AUC) schematic displaying the larger area for uninhibited ACE2 binding versus the area from curves showing competition with ACE2. (D) AUC of IgGs purified from immunized rabbit sera (IgGr low dose, blue; IgGr high dose, red) versus naive IgGr or day 0 IgGr. (E) AUC of sera from immunized rabbits (low dose rabbit sera, blue; high dose rabbit sera, red) versus naive rabbit sera or day 0 rabbit sera. (F) AUC of sera from immunized guinea pigs at week 2 (dark blue) and individual animals (blue), naive sera (gray), and pooled day 0 sera from all animals (black). The pooled immunized curve displayed a comparable AUC to the average AUC from all individual immunized animals.

    Techniques Used: Blocking Assay, Binding Assay, Concentration Assay, Purification

    Related Articles

    Functional Assay:

    Article Title: BEVA2.0: Modular Assembly of Golden Gate-Compatible Vectors with Expanded Utility for Genetic Engineering
    Article Snippet: .. New BEVA modules were designed based on functional units from pre-existing cloning vectors and synthesized free of internal BsaI, BpiI (BbsI) and BsmBI (Esp3I) sites by Twist Bioscience in the Amp R backbone “pTwist Amp High Copy”, Cm R backbone “pTwist Chlor High Copy, or cloned via BsaI into Cm R pGGAselect (New England Biolabs). ..

    Cloning:

    Article Title: BEVA2.0: Modular Assembly of Golden Gate-Compatible Vectors with Expanded Utility for Genetic Engineering
    Article Snippet: .. New BEVA modules were designed based on functional units from pre-existing cloning vectors and synthesized free of internal BsaI, BpiI (BbsI) and BsmBI (Esp3I) sites by Twist Bioscience in the Amp R backbone “pTwist Amp High Copy”, Cm R backbone “pTwist Chlor High Copy, or cloned via BsaI into Cm R pGGAselect (New England Biolabs). ..

    Synthesized:

    Article Title: BEVA2.0: Modular Assembly of Golden Gate-Compatible Vectors with Expanded Utility for Genetic Engineering
    Article Snippet: .. New BEVA modules were designed based on functional units from pre-existing cloning vectors and synthesized free of internal BsaI, BpiI (BbsI) and BsmBI (Esp3I) sites by Twist Bioscience in the Amp R backbone “pTwist Amp High Copy”, Cm R backbone “pTwist Chlor High Copy, or cloned via BsaI into Cm R pGGAselect (New England Biolabs). ..

    Clone Assay:

    Article Title: BEVA2.0: Modular Assembly of Golden Gate-Compatible Vectors with Expanded Utility for Genetic Engineering
    Article Snippet: .. New BEVA modules were designed based on functional units from pre-existing cloning vectors and synthesized free of internal BsaI, BpiI (BbsI) and BsmBI (Esp3I) sites by Twist Bioscience in the Amp R backbone “pTwist Amp High Copy”, Cm R backbone “pTwist Chlor High Copy, or cloned via BsaI into Cm R pGGAselect (New England Biolabs). ..

    other:

    Article Title: A massively parallel reporter assay library to screen short synthetic promoters in mammalian cells
    Article Snippet: Plasmids used in this study are listed in Supplementary Data . pcDNA3.1_eGFP was generated by PCR amplifying the eGFP CDS from Arch(D95H)-eGFP (Addgene #51081) and inserting into pcDNA3.1(-)/ myc -His A using the EcoRI and NotI restriction sites. pcDNA3.1_Signal-Flag-ADRB2 was generated by PCR amplifying the ADRB2 CDS from ADRB2-Tango (Addgene #66220) (introducing a stop codon) and inserting into pcDNA3.1(-)/ myc -His A using Gibson assembly. pcDNA3.1_Signal-Flag-DRD2 was generated by PCR amplifying the DRD2 CDS from DRD2-Tango (Addgene #66269) (introducing a stop codon) and inserting into pcDNA3.1(+) using the NotI and XhoI restriction sites. pcDNA3.1_Signal-Flag-DRD1 was generated by PCR amplifying the DRD1 CDS from DRD1-Tango (Addgene #66268) (introducing a stop codon) and inserting into pcDNA3.1(-)/ myc -His A using the BamHI and KpnI restriction sites. pcDNA3.1-GPR91 was generated by PCR amplifying the GPR91 CDS from SUCNR1-Tango (Addgene #66507) (introducing a stop codon) and inserting into pcDNA3.1(-)/ myc -His A using Gibson assembly. pcDNA3.1_Signal-Flag-OPRM1 was generated by PCR amplifying the OPRM1 CDS from OPRM1-Tango (Addgene #66464) (introducing a stop codon) and inserting into pcDNA3.1(+) using the NotI restriction site. pcDNA3.1_Signal-Flag-NTSR1 was generated by PCR amplifying the NTSR1 CDS from NTSR1-Tango (Addgene #66457) (introducing a stop codon) and inserting into pcDNA3.1 using the HindIII and AflII restriction sites. pTwist_HA-PAR1 was purchased from Twist Bioscience. pcDNA3.1_Signal-Flag-MRGPRX2 and pcDNA5/FRT/Signal-Flag-HTR2A were previously described .

    Article Title: A massively parallel reporter assay library to screen short synthetic promoters in mammalian cells.
    Article Snippet: DNA removal from RNA fractions was confirmed by RT-PCR using the SuperScript IV One-Step RT-PCR System (Invitrogen) with and without addition of SuperScript IV RT Mix, followed by agarose gel electrophoresis.

    Article Title: Rapid In-Field Detection of Airborne Pathogens Using Loop-Mediated Isothermal Amplification (LAMP)
    Article Snippet: Transformation of E. coli: Vectors (pTwist Amp High Copy, Twist Bioscience, South San Francisco, CA, USA) containing LAMP gene targets for all pathogens were synthesized by Twist Bioscience (USA) and resuspended in 1X TE buffer according to the manufacturer’s instructions.

    Article Title: Coronavirus replicase epitopes induce cross-reactive CD8 T cell responses in SARS-CoV-2-naive people with HIV-1
    Article Snippet: Chromium Next GEM Single-Cell 5′ kits v.2 were used to generate VDJ libraries according to the manufacturer’s instructions (10X Genomics).

    Article Title: Rapid In-Field Detection of Airborne Pathogens Using Loop-Mediated Isothermal Amplification (LAMP)
    Article Snippet: Transformation of E. coli : Vectors (pTwist Amp High Copy, Twist Bioscience, South San Francisco, CA, USA) containing LAMP gene targets for all pathogens were synthesized by Twist Bioscience (USA) and resuspended in 1X TE buffer according to the manufacturer’s instructions.



    Similar Products

    94
    R&D Systems human fc sequence
    Human Fc Sequence, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+fc+sequence/Recombinant+Human+CD155%2FPVR+Fc+Chimera+Protein%2C+CF/us12415854-917-10-15
    Average 94 stars, based on 1 article reviews
    human fc sequence - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    90
    Thermo Fisher synthetic gene coding fusion hil-7 sequence sequence human igg2-fc
    Synthetic Gene Coding Fusion Hil 7 Sequence Sequence Human Igg2 Fc, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+fc+sequence/pm35667841-50-16-20
    Average 90 stars, based on 1 article reviews
    synthetic gene coding fusion hil-7 sequence sequence human igg2-fc - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    Antagen Pharmaceuticals a scfv-higg1 construct, where its scfv part utilizes anti-tnfα humira sequence to fuse with human igg1 fc,
    A Scfv Higg1 Construct, Where Its Scfv Part Utilizes Anti Tnfα Humira Sequence To Fuse With Human Igg1 Fc,, supplied by Antagen Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+fc+sequence/anti+mcd79b+pig+igg/pmc08315562-62-5-23
    Average 90 stars, based on 1 article reviews
    a scfv-higg1 construct, where its scfv part utilizes anti-tnfα humira sequence to fuse with human igg1 fc, - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    Bioneer Corporation human igg1 fc coding sequence
    Human Igg1 Fc Coding Sequence, supplied by Bioneer Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+fc+sequence/humanized+igg1+ab+antibody/10__34172_slash_ps__2020__37-24-15-18
    Average 90 stars, based on 1 article reviews
    human igg1 fc coding sequence - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    Twist Bioscience igg1 human fc sequence
    Animal <t>IgG</t> and serological competition. (A) IgG and serological competition schematic. Anti-His pAb captures SARS-CoV-2 spike protein. Immunized sera or IgG from small animals are used as competitors to block ACE2-IgHu receptor binding when premixed. ACE2-IgHu remaining is determined from an anti-human-HRP colorimetric readout. (B) IgGs present in a vaccinated BALB/c mouse block ACE2-IgHu binding with greater effect when the full-length SARS-CoV-2 S1-S2 spike protein is immobilized versus the S1 subunit by itself. (C) Area under the concentration-time curve (AUC) schematic displaying the larger area for uninhibited ACE2 binding versus the area from curves showing competition with ACE2. (D) AUC of IgGs purified from immunized rabbit sera (IgGr low dose, blue; IgGr high dose, red) versus naive IgGr or day 0 IgGr. (E) AUC of sera from immunized rabbits (low dose rabbit sera, blue; high dose rabbit sera, red) versus naive rabbit sera or day 0 rabbit sera. (F) AUC of sera from immunized guinea pigs at week 2 (dark blue) and individual animals (blue), naive sera (gray), and pooled day 0 sera from all animals (black). The pooled immunized curve displayed a comparable AUC to the average AUC from all individual immunized animals.
    Igg1 Human Fc Sequence, supplied by Twist Bioscience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+fc+sequence/ptwist+amp+high+copy/pmc07587116-45-3-19
    Average 90 stars, based on 1 article reviews
    igg1 human fc sequence - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    96
    Illumina Inc 4800 human genes
    Animal <t>IgG</t> and serological competition. (A) IgG and serological competition schematic. Anti-His pAb captures SARS-CoV-2 spike protein. Immunized sera or IgG from small animals are used as competitors to block ACE2-IgHu receptor binding when premixed. ACE2-IgHu remaining is determined from an anti-human-HRP colorimetric readout. (B) IgGs present in a vaccinated BALB/c mouse block ACE2-IgHu binding with greater effect when the full-length SARS-CoV-2 S1-S2 spike protein is immobilized versus the S1 subunit by itself. (C) Area under the concentration-time curve (AUC) schematic displaying the larger area for uninhibited ACE2 binding versus the area from curves showing competition with ACE2. (D) AUC of IgGs purified from immunized rabbit sera (IgGr low dose, blue; IgGr high dose, red) versus naive IgGr or day 0 IgGr. (E) AUC of sera from immunized rabbits (low dose rabbit sera, blue; high dose rabbit sera, red) versus naive rabbit sera or day 0 rabbit sera. (F) AUC of sera from immunized guinea pigs at week 2 (dark blue) and individual animals (blue), naive sera (gray), and pooled day 0 sera from all animals (black). The pooled immunized curve displayed a comparable AUC to the average AUC from all individual immunized animals.
    4800 Human Genes, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+fc+sequence/TruSight+One+Sequencing+Panel/pmc07322863-25-4-11
    Average 96 stars, based on 1 article reviews
    4800 human genes - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    94
    InvivoGen human fc sequence
    Animal <t>IgG</t> and serological competition. (A) IgG and serological competition schematic. Anti-His pAb captures SARS-CoV-2 spike protein. Immunized sera or IgG from small animals are used as competitors to block ACE2-IgHu receptor binding when premixed. ACE2-IgHu remaining is determined from an anti-human-HRP colorimetric readout. (B) IgGs present in a vaccinated BALB/c mouse block ACE2-IgHu binding with greater effect when the full-length SARS-CoV-2 S1-S2 spike protein is immobilized versus the S1 subunit by itself. (C) Area under the concentration-time curve (AUC) schematic displaying the larger area for uninhibited ACE2 binding versus the area from curves showing competition with ACE2. (D) AUC of IgGs purified from immunized rabbit sera (IgGr low dose, blue; IgGr high dose, red) versus naive IgGr or day 0 IgGr. (E) AUC of sera from immunized rabbits (low dose rabbit sera, blue; high dose rabbit sera, red) versus naive rabbit sera or day 0 rabbit sera. (F) AUC of sera from immunized guinea pigs at week 2 (dark blue) and individual animals (blue), naive sera (gray), and pooled day 0 sera from all animals (black). The pooled immunized curve displayed a comparable AUC to the average AUC from all individual immunized animals.
    Human Fc Sequence, supplied by InvivoGen, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+fc+sequence/pFUSE-hIgG2-Fc2/us10562980-2235-10-21
    Average 94 stars, based on 1 article reviews
    human fc sequence - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    90
    GenScript corporation codon-optimized sequences for human gdf11 and human gdf11pro-fc
    Animal <t>IgG</t> and serological competition. (A) IgG and serological competition schematic. Anti-His pAb captures SARS-CoV-2 spike protein. Immunized sera or IgG from small animals are used as competitors to block ACE2-IgHu receptor binding when premixed. ACE2-IgHu remaining is determined from an anti-human-HRP colorimetric readout. (B) IgGs present in a vaccinated BALB/c mouse block ACE2-IgHu binding with greater effect when the full-length SARS-CoV-2 S1-S2 spike protein is immobilized versus the S1 subunit by itself. (C) Area under the concentration-time curve (AUC) schematic displaying the larger area for uninhibited ACE2 binding versus the area from curves showing competition with ACE2. (D) AUC of IgGs purified from immunized rabbit sera (IgGr low dose, blue; IgGr high dose, red) versus naive IgGr or day 0 IgGr. (E) AUC of sera from immunized rabbits (low dose rabbit sera, blue; high dose rabbit sera, red) versus naive rabbit sera or day 0 rabbit sera. (F) AUC of sera from immunized guinea pigs at week 2 (dark blue) and individual animals (blue), naive sera (gray), and pooled day 0 sera from all animals (black). The pooled immunized curve displayed a comparable AUC to the average AUC from all individual immunized animals.
    Codon Optimized Sequences For Human Gdf11 And Human Gdf11pro Fc, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+fc+sequence/codon+optimized+sequences+for+human+gdf11+and+human+gdf11pro+fc/pmc06537384-52-8-12
    Average 90 stars, based on 1 article reviews
    codon-optimized sequences for human gdf11 and human gdf11pro-fc - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    96
    Illumina Inc human disease
    Animal <t>IgG</t> and serological competition. (A) IgG and serological competition schematic. Anti-His pAb captures SARS-CoV-2 spike protein. Immunized sera or IgG from small animals are used as competitors to block ACE2-IgHu receptor binding when premixed. ACE2-IgHu remaining is determined from an anti-human-HRP colorimetric readout. (B) IgGs present in a vaccinated BALB/c mouse block ACE2-IgHu binding with greater effect when the full-length SARS-CoV-2 S1-S2 spike protein is immobilized versus the S1 subunit by itself. (C) Area under the concentration-time curve (AUC) schematic displaying the larger area for uninhibited ACE2 binding versus the area from curves showing competition with ACE2. (D) AUC of IgGs purified from immunized rabbit sera (IgGr low dose, blue; IgGr high dose, red) versus naive IgGr or day 0 IgGr. (E) AUC of sera from immunized rabbits (low dose rabbit sera, blue; high dose rabbit sera, red) versus naive rabbit sera or day 0 rabbit sera. (F) AUC of sera from immunized guinea pigs at week 2 (dark blue) and individual animals (blue), naive sera (gray), and pooled day 0 sera from all animals (black). The pooled immunized curve displayed a comparable AUC to the average AUC from all individual immunized animals.
    Human Disease, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+fc+sequence/TruSight+One+Sequencing+Panel/10__3233_slash_jnd___189001-6817-10-17
    Average 96 stars, based on 1 article reviews
    human disease - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    Image Search Results


    Animal IgG and serological competition. (A) IgG and serological competition schematic. Anti-His pAb captures SARS-CoV-2 spike protein. Immunized sera or IgG from small animals are used as competitors to block ACE2-IgHu receptor binding when premixed. ACE2-IgHu remaining is determined from an anti-human-HRP colorimetric readout. (B) IgGs present in a vaccinated BALB/c mouse block ACE2-IgHu binding with greater effect when the full-length SARS-CoV-2 S1-S2 spike protein is immobilized versus the S1 subunit by itself. (C) Area under the concentration-time curve (AUC) schematic displaying the larger area for uninhibited ACE2 binding versus the area from curves showing competition with ACE2. (D) AUC of IgGs purified from immunized rabbit sera (IgGr low dose, blue; IgGr high dose, red) versus naive IgGr or day 0 IgGr. (E) AUC of sera from immunized rabbits (low dose rabbit sera, blue; high dose rabbit sera, red) versus naive rabbit sera or day 0 rabbit sera. (F) AUC of sera from immunized guinea pigs at week 2 (dark blue) and individual animals (blue), naive sera (gray), and pooled day 0 sera from all animals (black). The pooled immunized curve displayed a comparable AUC to the average AUC from all individual immunized animals.

    Journal: Journal of Clinical Microbiology

    Article Title: SARS-CoV-2 Assays To Detect Functional Antibody Responses That Block ACE2 Recognition in Vaccinated Animals and Infected Patients

    doi: 10.1128/JCM.01533-20

    Figure Lengend Snippet: Animal IgG and serological competition. (A) IgG and serological competition schematic. Anti-His pAb captures SARS-CoV-2 spike protein. Immunized sera or IgG from small animals are used as competitors to block ACE2-IgHu receptor binding when premixed. ACE2-IgHu remaining is determined from an anti-human-HRP colorimetric readout. (B) IgGs present in a vaccinated BALB/c mouse block ACE2-IgHu binding with greater effect when the full-length SARS-CoV-2 S1-S2 spike protein is immobilized versus the S1 subunit by itself. (C) Area under the concentration-time curve (AUC) schematic displaying the larger area for uninhibited ACE2 binding versus the area from curves showing competition with ACE2. (D) AUC of IgGs purified from immunized rabbit sera (IgGr low dose, blue; IgGr high dose, red) versus naive IgGr or day 0 IgGr. (E) AUC of sera from immunized rabbits (low dose rabbit sera, blue; high dose rabbit sera, red) versus naive rabbit sera or day 0 rabbit sera. (F) AUC of sera from immunized guinea pigs at week 2 (dark blue) and individual animals (blue), naive sera (gray), and pooled day 0 sera from all animals (black). The pooled immunized curve displayed a comparable AUC to the average AUC from all individual immunized animals.

    Article Snippet: DNA encoding the IgG1 human Fc sequence was added to the C terminus of the huACE2 and cloned by Twist Bioscience into a modified mammalian pVax-1 expression plasmid to generate the recombinant plasmid ACE2-IgHu.

    Techniques: Blocking Assay, Binding Assay, Concentration Assay, Purification